Literature DB >> 24231758

Timing of continuous renal replacement therapy and mortality in critically ill children*.

Vinai Modem1, Marita Thompson, Diane Gollhofer, Archana V Dhar, Raymond Quigley.   

Abstract

OBJECTIVES: Acute kidney injury and fluid overload frequently necessitate initiation of continuous renal replacement therapy in critically ill patients admitted to the ICU. In this study, our primary objective was to determine the effect of timing of initiation of continuous renal replacement therapy on ICU mortality in children requiring renal support for management of acute kidney injury and/or fluid overload.
DESIGN: Retrospective cohort study.
SETTING: Tertiary level, multidisciplinary PICU. PATIENTS: Children who received continuous renal replacement therapy for management of acute kidney injury and/or fluid overload from January 2000 through July 2009 were included in the study. Patients requiring extracorporeal life support and patients initiated on continuous renal replacement therapy for indications other than acute kidney injury and/or fluid overload were excluded.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Timing of initiation was defined chronologically as time from ICU admission to continuous renal replacement therapy initiation. Three hundred eighty treatments were performed during the study period, of which 190 were eligible and included in the study. Overall ICU mortality was 47% among the study population. Median timing of initiation was higher among nonsurvivors compared with survivors (3.4 vs 2.0 d, p = 0.001). Multivariable logistic regression analysis identified timing of initiation as an independent predictor of mortality with an adjusted odds ratio of 1.05 (95% CI, 1.01, 1.11). Fluid overload, indication for continuous renal replacement therapy initiation, severity of illness at ICU admission, and active oncologic diagnosis were the other independent predictors of mortality that were identified in the final regression model. In the survival analysis, late initiators (> 5 d) had higher mortality than early initiators (≤ 5 d) with a hazard ratio of 1.56 (95% CI, 1.02, 2.37).
CONCLUSIONS: Earlier initiation of continuous renal replacement therapy was associated with lower mortality in this cohort of critically ill children. Future studies should focus on early identification of such children who may benefit from early continuous renal replacement therapy initiation.

Entities:  

Mesh:

Year:  2014        PMID: 24231758     DOI: 10.1097/CCM.0000000000000039

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  30 in total

1.  Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury.

Authors:  Ron Wald; Neill K J Adhikari; Orla M Smith; Matthew A Weir; Karen Pope; Ashley Cohen; Kevin Thorpe; Lauralyn McIntyre; Francois Lamontagne; Mark Soth; Margaret Herridge; Stephen Lapinsky; Edward Clark; Amit X Garg; Swapnil Hiremath; David Klein; C David Mazer; Robert M A Richardson; M Elizabeth Wilcox; Jan O Friedrich; Karen E A Burns; Sean M Bagshaw
Journal:  Kidney Int       Date:  2015-07-08       Impact factor: 10.612

2.  Outcome of invasive mechanical ventilation after pediatric allogeneic hematopoietic SCT: results from a prospective, multicenter registry.

Authors:  J P J van Gestel; M B Bierings; S Dauger; J-H Dalle; P Pavlíček; P Sedláček; L M Monteiro; A Lankester; C W Bollen
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

3.  Clinical Features and Indications Associated with Mortality in Continuous Renal Replacement Therapy for Pediatric Patients.

Authors:  Guntulu Sık; Asuman Demirbuga; Seda Günhar; Kemal Nisli; Agop Citak
Journal:  Indian J Pediatr       Date:  2019-02-11       Impact factor: 1.967

4.  Implementing a practice change: early initiation of continuous renal replacement therapy during neonatal extracorporeal life support standardizes care and improves short-term outcomes.

Authors:  Heidi J Murphy; John B Cahill; Katherine E Twombley; David J Annibale; James R Kiger
Journal:  J Artif Organs       Date:  2017-10-30       Impact factor: 1.731

Review 5.  Peritoneal dialysis for the management of pediatric patients with acute kidney injury.

Authors:  Anil Vasudevan; Kishore Phadke; Hui-Kim Yap
Journal:  Pediatr Nephrol       Date:  2016-10-28       Impact factor: 3.714

6.  The Japanese Clinical Practice Guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  J Intensive Care       Date:  2018-08-13

7.  Association Between Fluid Balance and Outcomes in Critically Ill Children: A Systematic Review and Meta-analysis.

Authors:  Rashid Alobaidi; Catherine Morgan; Rajit K Basu; Erin Stenson; Robin Featherstone; Sumit R Majumdar; Sean M Bagshaw
Journal:  JAMA Pediatr       Date:  2018-03-01       Impact factor: 16.193

Review 8.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

9.  Smaller circuits for smaller patients: improving renal support therapy with Aquadex™.

Authors:  David Askenazi; Daryl Ingram; Suzanne White; Monica Cramer; Santiago Borasino; Carl Coghill; Lynn Dill; Frank Tenney; Dan Feig; Sahar Fathallah-Shaykh
Journal:  Pediatr Nephrol       Date:  2015-11-16       Impact factor: 3.714

10.  Developmental Origins for Kidney Disease Due to Shroom3 Deficiency.

Authors:  Hadiseh Khalili; Alexandra Sull; Sanjay Sarin; Felix J Boivin; Rami Halabi; Bruno Svajger; Aihua Li; Valerie Wenche Cui; Thomas Drysdale; Darren Bridgewater
Journal:  J Am Soc Nephrol       Date:  2016-03-03       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.